Qualigen Therapeutics, Inc. — Director's Dealing 2018

Jun 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2018-06-26

Reporting Person: Ritter Andrew J (CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-26	Non-qualified Stock Option (Right to Buy)	$2.73	A	150000	Acquired	2028-06-26	Common Stock (150000)	Direct

Footnotes

F1: The option vests in forty-eight (48) equal monthly installments beginning on July 26, 2018 with the balance vesting on the 26th day of each calendar month therafter until vested in full.